"10.1371_journal.pgen.1005710","plos genetics","2015-12-17T00:00:00Z","Anmol Kumar; Jaakko Kopra; Kärt Varendi; Lauriina L Porokuokka; Anne Panhelainen; Satu Kuure; Pepin Marshall; Nina Karalija; Mari-Anne Härma; Carolina Vilenius; Kersti Lilleväli; Triin Tekko; Jelena Mijatovic; Nita Pulkkinen; Madis Jakobson; Maili Jakobson; Roxana Ola; Erik Palm; Maria Lindahl; Ingrid Strömberg; Vootele Võikar; T Petteri Piepponen; Mart Saarma; Jaan-Olle Andressoo","Institute of Biotechnology, University of Helsinki, Helsinki, Finland; Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland; Department of Histology and Cell Biology, Umeå University, Umeå, Sweden; Department of Physiology, Institute of Biomedicine and Translational Medicine, University of Tartu, Tartu, Estonia; Department of Biochemistry and Developmental Biology, Institute of Biomedicine, University of Helsinki, Helsinki, Finland; Neuroscience Center and Department of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland","Conceived and designed the experiments: JOA MS IS TPP. Performed the experiments: JOA AK JK LP AP KV SK PM NK MAH CV TT JM NP MadJ MaiJ RO EP ML VV. Analyzed the data: JOA AK JK LP AP KV SK PM NK MAH CV JM MadJ MaiJ VV IS PP MS. Contributed reagents/materials/analysis tools: JOA MS IS TPP. Wrote the paper: JOA KV JK. Performed the in vitro miRNA experiments: AK KV MAH. Northern blot and RBP analysis: AK. Analyzed kidney development: SK. Dissected the brains, measured DA levels and counted DA neurons: JK JM. Counted striatal DA varicosities: JK. In situ hybridization analyses of Gdnf: MadJ RO EP KL TT. Experiments with Dicerfloxed/floxed primary neurons: MaiJ. Behavioral studies with amphetamine and the corridor test: JK. 6-OHDA injections and analysis: JK JM. Other behavioral assays: CV VV. RNAscope analysis, western blotting of Pi-ERK, DAT, and TH protein levels: LP. Gdnf mRNA QPCR analysis in various brain regions: KV MAH. Fast-scan cyclic voltammetry analyses: AP. Microdialysis: NP. Amperometry: PM NK. Designed experiments: KV IS ML TPP. Initiated the in vivo Gdnf studies, provided funding, designed experiments: MS. Contributed to the writing of the paper: KV JK. Conceived the idea of preventing transcription into Gdnf 3UTR, designed and generated GDNF hypermorphic mice, performed experiments, designed experiments, provided funding, and wrote the paper: JOA.","I have read the journals policy and the authors of this manuscript have the following competing interests: JOA and MS declare that one patent application regarding the reported findings is currently pending.","2015","12","Anmol Kumar","AK",24,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
